Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 9 , ISSUE 4 ( October, 2005 ) > List of Articles

ORIGINAL ARTICLE

Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia-a prospective cohort study

Panwar Rakshit, Vidya S. Nagar, Alaka K. Deshpande

Keywords : APACHE III (Acute Physiology, Age and Chronic Health Evaluation) Scores, Comorbid illnesses, Mechanical ventilation, Mortality, Nonsurvivors, PaO2/FiO2 ratio, Ventilator-associated pneumonia

Citation Information : Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia-a prospective cohort study. Indian J Crit Care Med 2005; 9 (4):211-216.

DOI: 10.4103/0972-5229.19761

License: CC BY-ND 3.0

Published Online: 00-10-2005

Copyright Statement:  Copyright © 2005; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Context and Aim: Ventilator-associated pneumonia (VAP) remains to be the commonest cause of hospital morbidity and mortality in spite of advances in diagnostic techniques and management. This project aims to study the various risk factors and the common microbial flora associated with VAP. It also evaluates the use of APACHEIII scores for prognostication. Study Design: A prospective cohort study was conducted over 1 year in medical critical care unit (CCU) of a tertiary-care teaching hospital. Methods and Material: VAP was diagnosed using the clinical pulmonary infection score (CPIS) of more than 6. The study cohort comprised 51 patients. All CCU patients requiring mechanical ventilation for more than 48 h formed the study group. Statistical Analysis Used: Univariate analysis, c2-test, and paired “t-test.” Results: Twenty-four out of fifty-one cases developed VAP. These cases had an average APACHEIII score of more than 55 on admission to critical care unit (CCU). They needed prolonged mechanical ventilation and had lower PaO2/FiO2 ratio as compared with the remaining patients who did not develop VAP. Pseudomonas aeroginosa was the commonest and most lethal organism. The mortality in the VAP group was 37% and correlated very well with higher APACHEIII scores on admission. Conclusions: Longer duration of mechanical ventilation and the need of reintubation are associated with proportionate rise in the incidence of VAP. Deteriorating PaO2/FiO2 ratio correlated well with the onset of VAP. Higher APACHEIII scores on admission stratify the mortality risk.


PDF Share
  1. Pingleton SK, Fagon JY, Leeper KV. Patient selection for Clinical investigation of VAP. Chest 1992;102;553-8.
  2. George DL. Epidemiology of nosocomial pneumonia in MICU. Med Clin Chest Med 1995;16:29-44.
  3. Kollef MH, Silver P, Murphy DM. The effect of VAP in determining mortality. Chest 1995;108:1655-62.
  4. Sa Borges M, Correa H. Variations in etiology of VAP. Respirator Crit Care Med 1999;160:608-13.
  5. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, et al. Nosocomial Pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respirator Dis 1989;139:877-84.
  6. Fagon J, Chastre J. Evaluation of clinical judgement in identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993;103:547-53.
  7. Pugin J, Auckenthaler R, Mili N. Diagnosis of VAP. Am Rev Respirator Dis 1991;143:1121-9.
  8. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M. The APACHEIII prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.
  9. Chastre J, Fagon JY. Ventilator-associated pneumonia, Principles of Critical Care; 1998. pp. 617-47.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.